Dear Doctor Letter (Rote-Hand-Brief) on Multaq® (dronedarone): Restrictions regarding the use of Multaq®
2011.09.30
Active substance: dronedarone
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has decided on restrictions as well as additional contraindications and warnings regarding the use of Multaq®.
(SPC-Summary of Product Characteristics - available in German only)
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN